

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | axon ensheathment in central nervous system (GO:0032291) | 8.77186381 |
| 2 | central nervous system myelination (GO:0022010) | 8.77186381 |
| 3 | fatty acid elongation (GO:0030497) | 7.26638317 |
| 4 | ensheathment of neurons (GO:0007272) | 6.32356808 |
| 5 | axon ensheathment (GO:0008366) | 6.32356808 |
| 6 | myelination (GO:0042552) | 6.17103042 |
| 7 | long-chain fatty acid biosynthetic process (GO:0042759) | 4.97675489 |
| 8 | myelin maintenance (GO:0043217) | 4.78211830 |
| 9 | cholesterol biosynthetic process (GO:0006695) | 4.77606261 |
| 10 | negative regulation of neurotransmitter secretion (GO:0046929) | 4.57717190 |
| 11 | long-chain fatty-acyl-CoA biosynthetic process (GO:0035338) | 4.50173144 |
| 12 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 4.45625799 |
| 13 | negative regulation of neurotransmitter transport (GO:0051589) | 4.18562348 |
| 14 | sterol biosynthetic process (GO:0016126) | 4.17707606 |
| 15 | myelination in peripheral nervous system (GO:0022011) | 4.11684505 |
| 16 | peripheral nervous system axon ensheathment (GO:0032292) | 4.11684505 |
| 17 | long-chain fatty-acyl-CoA metabolic process (GO:0035336) | 4.09120145 |
| 18 | response to methylmercury (GO:0051597) | 4.05941002 |
| 19 | synaptic vesicle maturation (GO:0016188) | 4.02381412 |
| 20 | L-amino acid import (GO:0043092) | 4.01889880 |
| 21 | fatty-acyl-CoA biosynthetic process (GO:0046949) | 4.01821549 |
| 22 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 3.81282861 |
| 23 | peptidyl-tyrosine autophosphorylation (GO:0038083) | 3.79523884 |
| 24 | import into cell (GO:0098657) | 3.73068302 |
| 25 | response to lipoprotein particle (GO:0055094) | 3.70564870 |
| 26 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 3.70465190 |
| 27 | regulation of collateral sprouting (GO:0048670) | 3.68534642 |
| 28 | glycerophospholipid catabolic process (GO:0046475) | 3.67520669 |
| 29 | glutamate secretion (GO:0014047) | 3.66357826 |
| 30 | asymmetric protein localization (GO:0008105) | 3.64437381 |
| 31 | negative regulation of protein localization to cell surface (GO:2000009) | 3.62346489 |
| 32 | photoreceptor cell differentiation (GO:0046530) | 3.62011930 |
| 33 | eye photoreceptor cell differentiation (GO:0001754) | 3.62011930 |
| 34 | apical protein localization (GO:0045176) | 3.62007025 |
| 35 | regulation of synaptic vesicle exocytosis (GO:2000300) | 3.61638242 |
| 36 | fatty-acyl-CoA metabolic process (GO:0035337) | 3.61122012 |
| 37 | creatine metabolic process (GO:0006600) | 3.58829428 |
| 38 | oligodendrocyte differentiation (GO:0048709) | 3.57616486 |
| 39 | isoprenoid biosynthetic process (GO:0008299) | 3.53792099 |
| 40 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 3.48016603 |
| 41 | cellular potassium ion homeostasis (GO:0030007) | 3.47397601 |
| 42 | establishment of mitochondrion localization (GO:0051654) | 3.44595970 |
| 43 | amyloid precursor protein metabolic process (GO:0042982) | 3.39903594 |
| 44 | negative regulation of peptidyl-threonine phosphorylation (GO:0010801) | 3.39164084 |
| 45 | astrocyte development (GO:0014002) | 3.36690966 |
| 46 | nerve growth factor signaling pathway (GO:0038180) | 3.34247917 |
| 47 | locomotory exploration behavior (GO:0035641) | 3.33842113 |
| 48 | synaptic vesicle exocytosis (GO:0016079) | 3.29870772 |
| 49 | sodium ion export (GO:0071436) | 3.29765191 |
| 50 | acyl-CoA biosynthetic process (GO:0071616) | 3.27936106 |
| 51 | thioester biosynthetic process (GO:0035384) | 3.27936106 |
| 52 | presynaptic membrane organization (GO:0097090) | 3.21298154 |
| 53 | neuronal action potential propagation (GO:0019227) | 3.19428159 |
| 54 | virion attachment to host cell (GO:0019062) | 3.18239697 |
| 55 | adhesion of symbiont to host cell (GO:0044650) | 3.18239697 |
| 56 | very long-chain fatty acid metabolic process (GO:0000038) | 3.17597880 |
| 57 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 3.15408136 |
| 58 | presynaptic membrane assembly (GO:0097105) | 3.14475368 |
| 59 | regulation of synaptic vesicle transport (GO:1902803) | 3.13373899 |
| 60 | substantia nigra development (GO:0021762) | 3.13360263 |
| 61 | regulation of lipoprotein metabolic process (GO:0050746) | 3.10825070 |
| 62 | cerebellar Purkinje cell differentiation (GO:0021702) | 3.09519977 |
| 63 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 3.09165644 |
| 64 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 3.06981908 |
| 65 | regulation of ARF protein signal transduction (GO:0032012) | 3.04161059 |
| 66 | vocalization behavior (GO:0071625) | 3.02073043 |
| 67 | negative regulation of axonogenesis (GO:0050771) | 2.91287558 |
| 68 | response to redox state (GO:0051775) | 2.91233244 |
| 69 | amino acid import (GO:0043090) | 2.90101579 |
| 70 | protein localization to endosome (GO:0036010) | 2.89887593 |
| 71 | peripheral nervous system development (GO:0007422) | 2.89816396 |
| 72 | regulation of neuronal synaptic plasticity (GO:0048168) | 2.88625243 |
| 73 | positive regulation of oligodendrocyte differentiation (GO:0048714) | 2.87839750 |
| 74 | positive regulation of phosphoprotein phosphatase activity (GO:0032516) | 2.84734206 |
| 75 | glutamate receptor signaling pathway (GO:0007215) | 2.83306721 |
| 76 | membrane tubulation (GO:0097320) | 2.83076688 |
| 77 | phospholipid translocation (GO:0045332) | 2.79269579 |
| 78 | lipid translocation (GO:0034204) | 2.79269579 |
| 79 | transmission of nerve impulse (GO:0019226) | 2.77396589 |
| 80 | synaptic transmission, glutamatergic (GO:0035249) | 2.76980576 |
| 81 | establishment of nucleus localization (GO:0040023) | 2.74699147 |
| 82 | exploration behavior (GO:0035640) | 2.74481645 |
| 83 | cellular sodium ion homeostasis (GO:0006883) | 2.72914811 |
| 84 | magnesium ion transport (GO:0015693) | 2.72371681 |
| 85 | neurotransmitter secretion (GO:0007269) | 2.67650180 |
| 86 | glycosylceramide metabolic process (GO:0006677) | 2.67340315 |
| 87 | protein palmitoylation (GO:0018345) | 2.66560956 |
| 88 | neuron remodeling (GO:0016322) | 2.65796815 |
| 89 | axonal fasciculation (GO:0007413) | 2.64485567 |
| 90 | neurotransmitter-gated ion channel clustering (GO:0072578) | 2.63412436 |
| 91 | cell communication by electrical coupling (GO:0010644) | 2.62159201 |
| 92 | negative regulation of axon extension (GO:0030517) | 2.61121826 |
| 93 | cerebral cortex radially oriented cell migration (GO:0021799) | 2.60939602 |
| 94 | potassium ion import (GO:0010107) | 2.59183633 |
| 95 | dendritic spine morphogenesis (GO:0060997) | 2.58337117 |
| 96 | potassium ion homeostasis (GO:0055075) | 2.57570964 |
| 97 | neuronal ion channel clustering (GO:0045161) | 2.57403964 |
| 98 | neuron cell-cell adhesion (GO:0007158) | 2.55802287 |
| 99 | amyloid precursor protein catabolic process (GO:0042987) | 2.55119564 |
| 100 | gamma-aminobutyric acid signaling pathway (GO:0007214) | 2.54536581 |
| 101 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 2.54492787 |
| 102 | Rap protein signal transduction (GO:0032486) | 2.53651670 |
| 103 | adult walking behavior (GO:0007628) | 2.51728751 |
| 104 | Leydig cell differentiation (GO:0033327) | 2.51710470 |
| 105 | triglyceride biosynthetic process (GO:0019432) | 2.51666436 |
| 106 | peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan (GO:0019800) | 2.51582425 |
| 107 | regulation of calcineurin-NFAT signaling cascade (GO:0070884) | 2.50858331 |
| 108 | postsynaptic membrane organization (GO:0001941) | 2.50750714 |
| 109 | regulation of Rap GTPase activity (GO:0032317) | 2.50623080 |
| 110 | positive regulation of neurological system process (GO:0031646) | 2.50392426 |
| 111 | regulation of long-term neuronal synaptic plasticity (GO:0048169) | 2.50196012 |
| 112 | axon development (GO:0061564) | 2.48061358 |
| 113 | regulation of glutamate receptor signaling pathway (GO:1900449) | 2.47608934 |
| 114 | neuron-neuron synaptic transmission (GO:0007270) | 2.46824000 |
| 115 | negative regulation of inclusion body assembly (GO:0090084) | 2.46286636 |
| 116 | adhesion of symbiont to host (GO:0044406) | 2.46274179 |
| 117 | cellular response to epinephrine stimulus (GO:0071872) | 2.45780630 |
| 118 | positive regulation of Rap GTPase activity (GO:0032854) | 2.45231089 |
| 119 | gamma-aminobutyric acid transport (GO:0015812) | 2.44850992 |
| 120 | positive regulation of calcium ion transmembrane transporter activity (GO:1901021) | 2.44156357 |
| 121 | macroautophagy (GO:0016236) | 2.44028716 |
| 122 | detection of temperature stimulus involved in sensory perception (GO:0050961) | 2.43936821 |
| 123 | detection of temperature stimulus involved in sensory perception of pain (GO:0050965) | 2.43936821 |
| 124 | regulation of neurotransmitter secretion (GO:0046928) | 2.43845931 |
| 125 | nucleus localization (GO:0051647) | 2.42866614 |
| 126 | Golgi to endosome transport (GO:0006895) | 2.41219803 |
| 127 | negative regulation of cytosolic calcium ion concentration (GO:0051481) | 2.41040280 |
| 128 | neutral lipid biosynthetic process (GO:0046460) | 2.39756222 |
| 129 | acylglycerol biosynthetic process (GO:0046463) | 2.39756222 |
| 130 | cerebellar granule cell differentiation (GO:0021707) | 2.39689160 |
| 131 | regulation of voltage-gated calcium channel activity (GO:1901385) | 2.38978269 |
| 132 | neurotransmitter uptake (GO:0001504) | 2.37025803 |
| 133 | cilium or flagellum-dependent cell motility (GO:0001539) | 2.36851915 |
| 134 | regulation of cell communication by electrical coupling (GO:0010649) | 2.36570494 |
| 135 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 2.36421129 |
| 136 | membrane depolarization during action potential (GO:0086010) | 2.35538769 |
| 137 | cholesterol metabolic process (GO:0008203) | 2.35416239 |
| 138 | regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882) | 2.35373520 |
| 139 | limb bud formation (GO:0060174) | 2.34785438 |
| 140 | vesicle transport along microtubule (GO:0047496) | 2.33960318 |
| 141 | long-term memory (GO:0007616) | 2.33447909 |
| 142 | positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316) | 2.33228380 |
| 143 | membrane assembly (GO:0071709) | 2.33059203 |
| 144 | negative regulation of dendrite morphogenesis (GO:0050774) | 2.31149449 |
| 145 | cell differentiation in hindbrain (GO:0021533) | 2.31065306 |
| 146 | regulation of synaptic plasticity (GO:0048167) | 2.29423267 |
| 147 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 2.29009887 |
| 148 | activation of protein kinase A activity (GO:0034199) | 2.27933303 |
| 149 | cell communication involved in cardiac conduction (GO:0086065) | 2.26997661 |
| 150 | response to nerve growth factor (GO:1990089) | 2.26989856 |
| 151 | cellular response to nerve growth factor stimulus (GO:1990090) | 2.26989856 |
| 152 | regulation of atrial cardiac muscle cell membrane depolarization (GO:0060371) | 2.26971290 |
| 153 | positive regulation of potassium ion transmembrane transporter activity (GO:1901018) | 2.26819838 |
| 154 | neuromuscular process controlling balance (GO:0050885) | 2.26804884 |
| 155 | layer formation in cerebral cortex (GO:0021819) | 2.25284808 |
| 156 | long-term synaptic potentiation (GO:0060291) | 2.25165675 |
| 157 | clathrin coat assembly (GO:0048268) | 2.25006268 |
| 158 | cytoskeletal anchoring at plasma membrane (GO:0007016) | 2.24358125 |
| 159 | acidic amino acid transport (GO:0015800) | 2.24175512 |
| 160 | positive regulation of epidermal growth factor-activated receptor activity (GO:0045741) | 2.24134423 |
| 161 | cellular response to monoamine stimulus (GO:0071868) | 2.23831933 |
| 162 | cellular response to catecholamine stimulus (GO:0071870) | 2.23831933 |
| 163 | regulation of dendritic spine development (GO:0060998) | 2.23830998 |
| 164 | iron coordination entity transport (GO:1901678) | 2.19978147 |
| 165 | membrane protein ectodomain proteolysis (GO:0006509) | 2.19746030 |
| 166 | thioester metabolic process (GO:0035383) | 2.19152802 |
| 167 | acyl-CoA metabolic process (GO:0006637) | 2.19152802 |
| 168 | dendrite morphogenesis (GO:0048813) | 2.18648924 |
| 169 | neuron recognition (GO:0008038) | 2.17481912 |
| 170 | leukocyte migration involved in inflammatory response (GO:0002523) | 2.16729161 |
| 171 | glial cell differentiation (GO:0010001) | 2.15351314 |
| 172 | positive regulation of actin filament depolymerization (GO:0030836) | 2.15345247 |
| 173 | Golgi to plasma membrane protein transport (GO:0043001) | 2.12585646 |
| 174 | semaphorin-plexin signaling pathway (GO:0071526) | 2.12469624 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | GBX2_23144817_ChIP-Seq_PC3_Human | 2.94289448 |
| 2 | * SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 2.34343364 |
| 3 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 2.28231985 |
| 4 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 2.11952053 |
| 5 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.99639198 |
| 6 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 1.95645768 |
| 7 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.95157978 |
| 8 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.93232966 |
| 9 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.90687932 |
| 10 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.89989671 |
| 11 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 1.89572578 |
| 12 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 1.89572578 |
| 13 | * OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.88607968 |
| 14 | EZH2_22144423_ChIP-Seq_EOC_Human | 1.88580293 |
| 15 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.87400925 |
| 16 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.82438825 |
| 17 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 1.79071752 |
| 18 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.78392553 |
| 19 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 1.74511207 |
| 20 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.73364041 |
| 21 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.64665756 |
| 22 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 1.63095175 |
| 23 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.58852725 |
| 24 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.58210324 |
| 25 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 1.55479672 |
| 26 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.55261245 |
| 27 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.53512681 |
| 28 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.51177109 |
| 29 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.49297454 |
| 30 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.48767039 |
| 31 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.47109906 |
| 32 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.46921425 |
| 33 | * ER_23166858_ChIP-Seq_MCF-7_Human | 1.45290479 |
| 34 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.41613791 |
| 35 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.41613791 |
| 36 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.39879661 |
| 37 | * SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.39007384 |
| 38 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.38230082 |
| 39 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.37277686 |
| 40 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.36222968 |
| 41 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 1.35006503 |
| 42 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.32653638 |
| 43 | YAP1_20516196_ChIP-Seq_MESCs_Mouse | 1.32304264 |
| 44 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.30683728 |
| 45 | * SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.30456480 |
| 46 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.29691784 |
| 47 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.26881657 |
| 48 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.26436338 |
| 49 | STAT3_24763339_ChIP-Seq_IMN-ESCs_Mouse | 1.25465550 |
| 50 | TP53_16413492_ChIP-PET_HCT116_Human | 1.25272964 |
| 51 | * TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 1.25167771 |
| 52 | P300_19829295_ChIP-Seq_ESCs_Human | 1.25027486 |
| 53 | STAT3_23295773_ChIP-Seq_U87_Human | 1.24156731 |
| 54 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.24094880 |
| 55 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.23917285 |
| 56 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.23260310 |
| 57 | * WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.20684640 |
| 58 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.19442601 |
| 59 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.19021030 |
| 60 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.18676975 |
| 61 | * RARB_27405468_Chip-Seq_BRAIN_Mouse | 1.16328745 |
| 62 | AR_19668381_ChIP-Seq_PC3_Human | 1.15733916 |
| 63 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.15711352 |
| 64 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.15345381 |
| 65 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.15282106 |
| 66 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.14963411 |
| 67 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 1.13904736 |
| 68 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 1.11685193 |
| 69 | AR_25329375_ChIP-Seq_VCAP_Human | 1.11268813 |
| 70 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 1.07978671 |
| 71 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.07700797 |
| 72 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.06081798 |
| 73 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.06038800 |
| 74 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.03676367 |
| 75 | * FOXM1_26456572_ChIP-Seq_MCF-7_Human | 1.03430812 |
| 76 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 1.03151254 |
| 77 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 1.02635746 |
| 78 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 1.02601106 |
| 79 | KDM2B_26808549_Chip-Seq_REH_Human | 1.02451998 |
| 80 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.01307305 |
| 81 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 1.01307305 |
| 82 | * TCF4_23295773_ChIP-Seq_U87_Human | 1.00789784 |
| 83 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.00272299 |
| 84 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 0.99674159 |
| 85 | PPARG_20176806_ChIP-Seq_3T3-L1_Mouse | 0.99274720 |
| 86 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 0.99009852 |
| 87 | TCF3_18467660_ChIP-ChIP_MESCs_Mouse | 0.98789304 |
| 88 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 0.98658822 |
| 89 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.98283773 |
| 90 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 0.97783845 |
| 91 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 0.97430151 |
| 92 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 0.96928171 |
| 93 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 0.96880335 |
| 94 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 0.96726493 |
| 95 | * E2F1_18555785_Chip-Seq_ESCs_Mouse | 0.96370693 |
| 96 | VDR_22108803_ChIP-Seq_LS180_Human | 0.95808569 |
| 97 | TP53_18474530_ChIP-ChIP_U2OS_Human | 0.95745162 |
| 98 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 0.95693902 |
| 99 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.94990814 |
| 100 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 0.94806943 |
| 101 | * TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.94417415 |
| 102 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 0.94086849 |
| 103 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 0.94035789 |
| 104 | LMO2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.93869272 |
| 105 | REST_21632747_ChIP-Seq_MESCs_Mouse | 0.93571249 |
| 106 | IGF1R_20145208_ChIP-Seq_DFB_Human | 0.93385127 |
| 107 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 0.92921266 |
| 108 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.92900043 |
| 109 | SMAD4_21741376_ChIP-Seq_EPCs_Human | 0.91038592 |
| 110 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 0.90894123 |
| 111 | CMYC_18555785_Chip-Seq_ESCs_Mouse | 0.90282321 |
| 112 | FUS_26573619_Chip-Seq_HEK293_Human | 0.88869697 |
| 113 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 0.88760810 |
| 114 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.88038106 |
| 115 | RUNX2_22187159_ChIP-Seq_PCA_Human | 0.87935178 |
| 116 | * NANOG_18555785_Chip-Seq_ESCs_Mouse | 0.87734699 |
| 117 | RXR_22108803_ChIP-Seq_LS180_Human | 0.87396363 |
| 118 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.87074228 |
| 119 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 0.86517955 |
| 120 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 0.86494005 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0000920_abnormal_myelination | 5.60711968 |
| 2 | MP0003690_abnormal_glial_cell | 3.58721213 |
| 3 | MP0003950_abnormal_plasma_membrane | 3.22571538 |
| 4 | MP0004270_analgesia | 3.20176842 |
| 5 | MP0000569_abnormal_digit_pigmentation | 3.10446361 |
| 6 | MP0003880_abnormal_central_pattern | 2.95828638 |
| 7 | MP0003329_amyloid_beta_deposits | 2.91253762 |
| 8 | MP0004885_abnormal_endolymph | 2.66091445 |
| 9 | MP0003634_abnormal_glial_cell | 2.56252591 |
| 10 | MP0003136_yellow_coat_color | 2.53819763 |
| 11 | MP0004859_abnormal_synaptic_plasticity | 2.44767051 |
| 12 | MP0005171_absent_coat_pigmentation | 2.41483398 |
| 13 | MP0002272_abnormal_nervous_system | 2.40233915 |
| 14 | MP0004742_abnormal_vestibular_system | 2.39760236 |
| 15 | MP0001486_abnormal_startle_reflex | 2.22664240 |
| 16 | MP0000778_abnormal_nervous_system | 2.04083386 |
| 17 | MP0003632_abnormal_nervous_system | 2.02920911 |
| 18 | MP0002064_seizures | 2.02480259 |
| 19 | MP0001984_abnormal_olfaction | 1.99508901 |
| 20 | MP0008438_abnormal_cutaneous_collagen | 1.98709208 |
| 21 | MP0010678_abnormal_skin_adnexa | 1.91703022 |
| 22 | MP0005409_darkened_coat_color | 1.86854089 |
| 23 | MP0001485_abnormal_pinna_reflex | 1.81912815 |
| 24 | MP0000604_amyloidosis | 1.81073611 |
| 25 | MP0001905_abnormal_dopamine_level | 1.76478528 |
| 26 | MP0002229_neurodegeneration | 1.74304755 |
| 27 | MP0003635_abnormal_synaptic_transmissio | 1.72589098 |
| 28 | MP0002734_abnormal_mechanical_nocicepti | 1.71615765 |
| 29 | MP0001529_abnormal_vocalization | 1.64434314 |
| 30 | MP0009046_muscle_twitch | 1.62663519 |
| 31 | MP0004272_abnormal_basement_membrane | 1.62574363 |
| 32 | MP0003631_nervous_system_phenotype | 1.59159211 |
| 33 | MP0009745_abnormal_behavioral_response | 1.57641983 |
| 34 | MP0000462_abnormal_digestive_system | 1.56608535 |
| 35 | MP0004130_abnormal_muscle_cell | 1.50063209 |
| 36 | MP0000383_abnormal_hair_follicle | 1.49211732 |
| 37 | MP0004381_abnormal_hair_follicle | 1.47628082 |
| 38 | MP0004142_abnormal_muscle_tone | 1.45926686 |
| 39 | MP0003633_abnormal_nervous_system | 1.45856082 |
| 40 | MP0002909_abnormal_adrenal_gland | 1.41437103 |
| 41 | MP0003879_abnormal_hair_cell | 1.40082728 |
| 42 | MP0005623_abnormal_meninges_morphology | 1.39767497 |
| 43 | MP0003787_abnormal_imprinting | 1.39145281 |
| 44 | MP0001661_extended_life_span | 1.39123593 |
| 45 | MP0001177_atelectasis | 1.34525847 |
| 46 | MP0005451_abnormal_body_composition | 1.31826967 |
| 47 | MP0008569_lethality_at_weaning | 1.31420804 |
| 48 | MP0000747_muscle_weakness | 1.31350155 |
| 49 | MP0002063_abnormal_learning/memory/cond | 1.29788797 |
| 50 | MP0001299_abnormal_eye_distance/ | 1.29681354 |
| 51 | MP0001968_abnormal_touch/_nociception | 1.28240365 |
| 52 | MP0005423_abnormal_somatic_nervous | 1.28144370 |
| 53 | MP0005551_abnormal_eye_electrophysiolog | 1.27209935 |
| 54 | MP0002882_abnormal_neuron_morphology | 1.26790884 |
| 55 | MP0002572_abnormal_emotion/affect_behav | 1.26595652 |
| 56 | MP0001440_abnormal_grooming_behavior | 1.26073224 |
| 57 | MP0004134_abnormal_chest_morphology | 1.25392289 |
| 58 | MP0001502_abnormal_circadian_rhythm | 1.23237603 |
| 59 | MP0002067_abnormal_sensory_capabilities | 1.22503862 |
| 60 | MP0003091_abnormal_cell_migration | 1.22188442 |
| 61 | MP0006276_abnormal_autonomic_nervous | 1.21364442 |
| 62 | MP0000955_abnormal_spinal_cord | 1.21188956 |
| 63 | MP0005058_abnormal_lysosome_morphology | 1.17867923 |
| 64 | MP0005646_abnormal_pituitary_gland | 1.14323681 |
| 65 | MP0002295_abnormal_pulmonary_circulatio | 1.13810788 |
| 66 | MP0009780_abnormal_chondrocyte_physiolo | 1.12843074 |
| 67 | MP0002638_abnormal_pupillary_reflex | 1.12580586 |
| 68 | MP0002733_abnormal_thermal_nociception | 1.12051632 |
| 69 | MP0002066_abnormal_motor_capabilities/c | 1.11770901 |
| 70 | MP0003195_calcinosis | 1.09968576 |
| 71 | MP0005386_behavior/neurological_phenoty | 1.08355216 |
| 72 | MP0004924_abnormal_behavior | 1.08355216 |
| 73 | MP0001970_abnormal_pain_threshold | 1.08351278 |
| 74 | MP0000647_abnormal_sebaceous_gland | 1.05275476 |
| 75 | MP0003183_abnormal_peptide_metabolism | 1.03996913 |
| 76 | MP0001851_eye_inflammation | 1.03113149 |
| 77 | MP0004147_increased_porphyrin_level | 1.02076806 |
| 78 | MP0004185_abnormal_adipocyte_glucose | 1.01691730 |
| 79 | MP0001963_abnormal_hearing_physiology | 1.00039961 |
| 80 | MP0003045_fibrosis | 0.98784053 |
| 81 | MP0010386_abnormal_urinary_bladder | 0.98623572 |
| 82 | MP0005410_abnormal_fertilization | 0.98493959 |
| 83 | MP0008260_abnormal_autophagy | 0.97754829 |
| 84 | MP0002090_abnormal_vision | 0.96827422 |
| 85 | MP0005408_hypopigmentation | 0.94834254 |
| 86 | MP0003122_maternal_imprinting | 0.94829020 |
| 87 | MP0005167_abnormal_blood-brain_barrier | 0.94231067 |
| 88 | MP0001879_abnormal_lymphatic_vessel | 0.92634944 |
| 89 | MP0010368_abnormal_lymphatic_system | 0.91364161 |
| 90 | MP0001346_abnormal_lacrimal_gland | 0.91326836 |
| 91 | MP0002752_abnormal_somatic_nervous | 0.91011911 |
| 92 | MP0005195_abnormal_posterior_eye | 0.88426947 |
| 93 | MP0000003_abnormal_adipose_tissue | 0.85947582 |
| 94 | MP0002184_abnormal_innervation | 0.85387988 |
| 95 | MP0002118_abnormal_lipid_homeostasis | 0.83777734 |
| 96 | MP0004043_abnormal_pH_regulation | 0.83633198 |
| 97 | MP0005275_abnormal_skin_tensile | 0.82615472 |
| 98 | MP0005388_respiratory_system_phenotype | 0.81058795 |
| 99 | MP0002133_abnormal_respiratory_system | 0.81058795 |
| 100 | MP0000579_abnormal_nail_morphology | 0.80233705 |
| 101 | MP0002971_abnormal_brown_adipose | 0.79910760 |
| 102 | MP0002822_catalepsy | 0.78565204 |
| 103 | MP0003806_abnormal_nucleotide_metabolis | 0.77402854 |
| 104 | MP0001501_abnormal_sleep_pattern | 0.76698315 |
| 105 | MP0003075_altered_response_to | 0.74270012 |
| 106 | MP0004484_altered_response_of | 0.73903840 |
| 107 | MP0002009_preneoplasia | 0.73901736 |
| 108 | MP0004858_abnormal_nervous_system | 0.72009905 |
| 109 | MP0002152_abnormal_brain_morphology | 0.71407546 |
| 110 | MP0004145_abnormal_muscle_electrophysio | 0.71334889 |
| 111 | MP0001958_emphysema | 0.71156697 |
| 112 | MP0005595_abnormal_vascular_smooth | 0.70433546 |
| 113 | MP0005187_abnormal_penis_morphology | 0.69754777 |
| 114 | MP0004036_abnormal_muscle_relaxation | 0.69161089 |
| 115 | MP0002735_abnormal_chemical_nociception | 0.68996941 |
| 116 | MP0005083_abnormal_biliary_tract | 0.68868302 |
| 117 | MP0005248_abnormal_Harderian_gland | 0.68327688 |
| 118 | MP0005503_abnormal_tendon_morphology | 0.67215168 |
| 119 | MP0005375_adipose_tissue_phenotype | 0.66095288 |
| 120 | MP0002168_other_aberrant_phenotype | 0.66016672 |
| 121 | MP0002557_abnormal_social/conspecific_i | 0.65922072 |
| 122 | MP0009384_cardiac_valve_regurgitation | 0.65552614 |
| 123 | MP0001348_abnormal_lacrimal_gland | 0.63214080 |
| 124 | MP0002736_abnormal_nociception_after | 0.62798904 |
| 125 | MP0003937_abnormal_limbs/digits/tail_de | 0.62383193 |
| 126 | MP0000639_abnormal_adrenal_gland | 0.62045448 |
| 127 | MP0004085_abnormal_heartbeat | 0.61902248 |
| 128 | MP0000013_abnormal_adipose_tissue | 0.61532532 |
| 129 | MP0004215_abnormal_myocardial_fiber | 0.61452652 |
| 130 | MP0008874_decreased_physiological_sensi | 0.60622513 |
| 131 | MP0004811_abnormal_neuron_physiology | 0.59760480 |
| 132 | MP0002108_abnormal_muscle_morphology | 0.59148096 |
| 133 | MP0000762_abnormal_tongue_morphology | 0.58826000 |
| 134 | MP0004084_abnormal_cardiac_muscle | 0.57577624 |
| 135 | MP0000534_abnormal_ureter_morphology | 0.56976702 |
| 136 | MP0003868_abnormal_feces_composition | 0.55126521 |
| 137 | MP0005666_abnormal_adipose_tissue | 0.55078891 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Termporal pattern (HP:0011008) | 6.41554454 |
| 2 | Insidious onset (HP:0003587) | 6.41554454 |
| 3 | Degeneration of the lateral corticospinal tracts (HP:0002314) | 6.28080925 |
| 4 | Atrophy/Degeneration involving the corticospinal tracts (HP:0007372) | 6.28080925 |
| 5 | Neurofibrillary tangles (HP:0002185) | 6.06022356 |
| 6 | Segmental peripheral demyelination/remyelination (HP:0003481) | 5.28027757 |
| 7 | Peripheral hypomyelination (HP:0007182) | 5.22148740 |
| 8 | Onion bulb formation (HP:0003383) | 5.09807220 |
| 9 | Abnormality of the corticospinal tract (HP:0002492) | 4.94842227 |
| 10 | Ulnar claw (HP:0001178) | 4.66765534 |
| 11 | Cerebral inclusion bodies (HP:0100314) | 4.57427913 |
| 12 | Sensory axonal neuropathy (HP:0003390) | 4.52204960 |
| 13 | Action tremor (HP:0002345) | 4.33425930 |
| 14 | Focal motor seizures (HP:0011153) | 4.14745854 |
| 15 | Febrile seizures (HP:0002373) | 4.13506334 |
| 16 | Parakeratosis (HP:0001036) | 4.08077004 |
| 17 | Supranuclear gaze palsy (HP:0000605) | 3.78302026 |
| 18 | Focal seizures (HP:0007359) | 3.70034968 |
| 19 | Intention tremor (HP:0002080) | 3.49013818 |
| 20 | Spastic gait (HP:0002064) | 3.42470630 |
| 21 | Abnormal auditory evoked potentials (HP:0006958) | 3.20965081 |
| 22 | Hammertoe (HP:0001765) | 3.08497468 |
| 23 | Dysmetria (HP:0001310) | 3.04564273 |
| 24 | Papillary thyroid carcinoma (HP:0002895) | 2.96492500 |
| 25 | Steppage gait (HP:0003376) | 2.95809879 |
| 26 | Progressive cerebellar ataxia (HP:0002073) | 2.91823943 |
| 27 | Decreased motor nerve conduction velocity (HP:0003431) | 2.91795786 |
| 28 | Akinesia (HP:0002304) | 2.88827944 |
| 29 | Peripheral demyelination (HP:0011096) | 2.88622854 |
| 30 | Foot dorsiflexor weakness (HP:0009027) | 2.83358470 |
| 31 | Scanning speech (HP:0002168) | 2.82426766 |
| 32 | Epileptic encephalopathy (HP:0200134) | 2.79403898 |
| 33 | Decreased number of peripheral myelinated nerve fibers (HP:0003380) | 2.78358290 |
| 34 | Congenital nonbullous ichthyosiform erythroderma (HP:0007479) | 2.74989699 |
| 35 | Ankle clonus (HP:0011448) | 2.74225965 |
| 36 | Alacrima (HP:0000522) | 2.73301232 |
| 37 | Papilledema (HP:0001085) | 2.72398986 |
| 38 | Slow saccadic eye movements (HP:0000514) | 2.72232973 |
| 39 | Hyperventilation (HP:0002883) | 2.70606034 |
| 40 | Myokymia (HP:0002411) | 2.63418511 |
| 41 | Arterial tortuosity (HP:0005116) | 2.59521554 |
| 42 | Cerebral hemorrhage (HP:0001342) | 2.54720507 |
| 43 | Abnormality of the foot musculature (HP:0001436) | 2.52013847 |
| 44 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 2.48992874 |
| 45 | Premature skin wrinkling (HP:0100678) | 2.47070529 |
| 46 | Overgrowth (HP:0001548) | 2.46017347 |
| 47 | Clumsiness (HP:0002312) | 2.44644388 |
| 48 | Diplopia (HP:0000651) | 2.44049610 |
| 49 | Abnormality of binocular vision (HP:0011514) | 2.44049610 |
| 50 | Obstructive sleep apnea (HP:0002870) | 2.43860683 |
| 51 | Vascular tortuosity (HP:0004948) | 2.42754195 |
| 52 | Postural tremor (HP:0002174) | 2.41174932 |
| 53 | Bundle branch block (HP:0011710) | 2.39844606 |
| 54 | Genetic anticipation (HP:0003743) | 2.36152672 |
| 55 | Infantile muscular hypotonia (HP:0008947) | 2.34823145 |
| 56 | Cerebral hypomyelination (HP:0006808) | 2.34581598 |
| 57 | Stridor (HP:0010307) | 2.34537362 |
| 58 | Hypoplasia of the iris (HP:0007676) | 2.34240701 |
| 59 | Impaired proprioception (HP:0010831) | 2.32931876 |
| 60 | Retinal dysplasia (HP:0007973) | 2.32032531 |
| 61 | Absence seizures (HP:0002121) | 2.31973617 |
| 62 | Absent speech (HP:0001344) | 2.30959253 |
| 63 | Postural instability (HP:0002172) | 2.29598716 |
| 64 | Drooling (HP:0002307) | 2.27978336 |
| 65 | Spastic paraparesis (HP:0002313) | 2.26429441 |
| 66 | Truncal ataxia (HP:0002078) | 2.24655760 |
| 67 | Congenital ichthyosiform erythroderma (HP:0007431) | 2.23884033 |
| 68 | Distal sensory impairment (HP:0002936) | 2.23797418 |
| 69 | Dialeptic seizures (HP:0011146) | 2.23131309 |
| 70 | Axonal loss (HP:0003447) | 2.22866574 |
| 71 | Anteriorly placed anus (HP:0001545) | 2.22473411 |
| 72 | Abnormal eating behavior (HP:0100738) | 2.21704092 |
| 73 | Hypomagnesemia (HP:0002917) | 2.21343643 |
| 74 | Aplasia involving bones of the extremities (HP:0009825) | 2.20946190 |
| 75 | Aplasia involving bones of the upper limbs (HP:0009823) | 2.20946190 |
| 76 | Aplasia of the phalanges of the hand (HP:0009802) | 2.20946190 |
| 77 | Hemiplegia (HP:0002301) | 2.20786888 |
| 78 | Lower limb muscle weakness (HP:0007340) | 2.20412751 |
| 79 | Coronal craniosynostosis (HP:0004440) | 2.19620129 |
| 80 | Autoamputation (HP:0001218) | 2.17667749 |
| 81 | Pheochromocytoma (HP:0002666) | 2.17296463 |
| 82 | Increased serum pyruvate (HP:0003542) | 2.16174288 |
| 83 | Abnormality of glycolysis (HP:0004366) | 2.16174288 |
| 84 | Dysmetric saccades (HP:0000641) | 2.15969670 |
| 85 | Impaired vibration sensation in the lower limbs (HP:0002166) | 2.15892199 |
| 86 | Gaze-evoked nystagmus (HP:0000640) | 2.15311934 |
| 87 | Increased circulating renin level (HP:0000848) | 2.12825086 |
| 88 | Excessive salivation (HP:0003781) | 2.11921762 |
| 89 | Increased CSF protein (HP:0002922) | 2.10881479 |
| 90 | Thickened helices (HP:0000391) | 2.08663627 |
| 91 | Abnormality of the ischium (HP:0003174) | 2.08647569 |
| 92 | Spastic tetraparesis (HP:0001285) | 2.08608195 |
| 93 | Decreased lacrimation (HP:0000633) | 2.07078894 |
| 94 | Decreased number of large peripheral myelinated nerve fibers (HP:0003387) | 2.05528986 |
| 95 | Generalized tonic-clonic seizures (HP:0002069) | 2.02024801 |
| 96 | Leukodystrophy (HP:0002415) | 1.99907864 |
| 97 | Metabolic alkalosis (HP:0200114) | 1.93943409 |
| 98 | Urinary urgency (HP:0000012) | 1.92663233 |
| 99 | Clonus (HP:0002169) | 1.91062997 |
| 100 | Impaired vibratory sensation (HP:0002495) | 1.88580995 |
| 101 | Megalencephaly (HP:0001355) | 1.88528371 |
| 102 | Hypoplastic pelvis (HP:0008839) | 1.88010360 |
| 103 | Broad-based gait (HP:0002136) | 1.87570123 |
| 104 | Hyperkalemia (HP:0002153) | 1.86636004 |
| 105 | Partial agenesis of the corpus callosum (HP:0001338) | 1.86579204 |
| 106 | Spastic paraplegia (HP:0001258) | 1.85281542 |
| 107 | Bronchomalacia (HP:0002780) | 1.85144798 |
| 108 | Difficulty running (HP:0009046) | 1.82858524 |
| 109 | Hyporeflexia of lower limbs (HP:0002600) | 1.82557304 |
| 110 | Esophageal atresia (HP:0002032) | 1.82161707 |
| 111 | Relative macrocephaly (HP:0004482) | 1.82075270 |
| 112 | Hypokalemic alkalosis (HP:0001949) | 1.80948891 |
| 113 | Morphological abnormality of the inner ear (HP:0011390) | 1.80410063 |
| 114 | Neoplasm of the heart (HP:0100544) | 1.79970296 |
| 115 | White forelock (HP:0002211) | 1.77918493 |
| 116 | Aortic aneurysm (HP:0004942) | 1.77624469 |
| 117 | Widely spaced teeth (HP:0000687) | 1.76773760 |
| 118 | Morphological abnormality of the pyramidal tract (HP:0002062) | 1.76714558 |
| 119 | Paraplegia (HP:0010550) | 1.76496565 |
| 120 | Paraparesis (HP:0002385) | 1.76480977 |
| 121 | Hyperaldosteronism (HP:0000859) | 1.76217222 |
| 122 | Poor eye contact (HP:0000817) | 1.74875987 |
| 123 | Hypophosphatemic rickets (HP:0004912) | 1.74866650 |
| 124 | Mild short stature (HP:0003502) | 1.73897573 |
| 125 | Neuroendocrine neoplasm (HP:0100634) | 1.73660431 |
| 126 | Synostosis involving the elbow (HP:0003938) | 1.73436609 |
| 127 | Humeroradial synostosis (HP:0003041) | 1.73436609 |
| 128 | Hepatosplenomegaly (HP:0001433) | 1.73073080 |
| 129 | Urinary bladder sphincter dysfunction (HP:0002839) | 1.71427426 |
| 130 | Cupped ear (HP:0000378) | 1.71154740 |
| 131 | Atonic seizures (HP:0010819) | 1.70975081 |
| 132 | Abnormal ciliary motility (HP:0012262) | 1.70489025 |
| 133 | Abnormality of the lower motor neuron (HP:0002366) | 1.69882180 |
| 134 | Abnormal pupillary function (HP:0007686) | 1.69539070 |
| 135 | Dysdiadochokinesis (HP:0002075) | 1.67811911 |
| 136 | Buphthalmos (HP:0000557) | 1.67105976 |
| 137 | Epileptiform EEG discharges (HP:0011182) | 1.66853764 |
| 138 | Amyotrophic lateral sclerosis (HP:0007354) | 1.66503183 |
| 139 | Generalized myoclonic seizures (HP:0002123) | 1.66384047 |
| 140 | Blue irides (HP:0000635) | 1.65434592 |
| 141 | Urinary incontinence (HP:0000020) | 1.65353123 |
| 142 | Sleep apnea (HP:0010535) | 1.64369666 |
| 143 | Premature rupture of membranes (HP:0001788) | 1.63387954 |
| 144 | Turricephaly (HP:0000262) | 1.63126172 |
| 145 | Hyperlipoproteinemia (HP:0010980) | 1.63124547 |
| 146 | Patchy hypopigmentation of hair (HP:0011365) | 1.62928637 |
| 147 | Loss of speech (HP:0002371) | 1.62303709 |
| 148 | Dynein arm defect of respiratory motile cilia (HP:0012255) | 1.61343817 |
| 149 | Absent/shortened dynein arms (HP:0200106) | 1.61343817 |
| 150 | Aortic dissection (HP:0002647) | 1.61303651 |
| 151 | Bell-shaped thorax (HP:0001591) | 1.61035806 |
| 152 | Impaired social interactions (HP:0000735) | 1.60391373 |
| 153 | Abnormal social behavior (HP:0012433) | 1.60391373 |
| 154 | Anomalous pulmonary venous return (HP:0010772) | 1.60366879 |
| 155 | Generalized hypopigmentation of hair (HP:0011358) | 1.59183340 |
| 156 | Abnormality of the periventricular white matter (HP:0002518) | 1.58747095 |
| 157 | Macroorchidism (HP:0000053) | 1.58104068 |
| 158 | Rhinitis (HP:0012384) | 1.57772110 |
| 159 | Hemiparesis (HP:0001269) | 1.57465367 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | STK39 | 6.33319953 |
| 2 | EPHB1 | 4.47260574 |
| 3 | OXSR1 | 4.16706566 |
| 4 | WNK4 | 2.60137388 |
| 5 | PKN1 | 2.45946057 |
| 6 | FGFR2 | 2.44848078 |
| 7 | AKT3 | 2.31044900 |
| 8 | TNIK | 2.30148341 |
| 9 | BCR | 2.26710892 |
| 10 | MAPKAPK5 | 2.08098291 |
| 11 | SGK2 | 2.03383435 |
| 12 | WNK1 | 2.02950826 |
| 13 | MET | 2.00827395 |
| 14 | DAPK2 | 1.95586768 |
| 15 | NTRK1 | 1.86084421 |
| 16 | PBK | 1.81625651 |
| 17 | UHMK1 | 1.66401884 |
| 18 | RIPK1 | 1.65009724 |
| 19 | EPHA4 | 1.62449066 |
| 20 | SGK3 | 1.60588062 |
| 21 | LATS2 | 1.59710905 |
| 22 | CDK19 | 1.53372328 |
| 23 | ICK | 1.52776538 |
| 24 | PRPF4B | 1.51844965 |
| 25 | TYRO3 | 1.43460508 |
| 26 | ROCK2 | 1.39726676 |
| 27 | CSNK1A1L | 1.39250313 |
| 28 | CAMKK1 | 1.37633051 |
| 29 | SGK223 | 1.37631042 |
| 30 | SGK494 | 1.37631042 |
| 31 | PAK6 | 1.37462656 |
| 32 | PNCK | 1.35163181 |
| 33 | LIMK1 | 1.33197024 |
| 34 | STK38 | 1.31148092 |
| 35 | CAMK1G | 1.29640216 |
| 36 | FRK | 1.28813999 |
| 37 | NEK6 | 1.28511206 |
| 38 | FGR | 1.27443981 |
| 39 | IRAK2 | 1.27217972 |
| 40 | CSNK1G3 | 1.26693920 |
| 41 | LATS1 | 1.24340298 |
| 42 | PDGFRA | 1.23984044 |
| 43 | CAMKK2 | 1.22997535 |
| 44 | CAMK2B | 1.12847756 |
| 45 | CSNK1G2 | 1.12820686 |
| 46 | MST4 | 1.11935406 |
| 47 | PAK3 | 1.10669434 |
| 48 | CSNK1G1 | 1.07912532 |
| 49 | MARK1 | 1.06911815 |
| 50 | MARK2 | 1.02777446 |
| 51 | DYRK1A | 1.01150274 |
| 52 | CLK1 | 1.01020484 |
| 53 | NEK9 | 1.00946813 |
| 54 | CASK | 1.00049596 |
| 55 | FGFR3 | 0.99653563 |
| 56 | JAK1 | 0.99604092 |
| 57 | CAMK2D | 0.97786427 |
| 58 | IRAK1 | 0.97057159 |
| 59 | PRKCQ | 0.94638341 |
| 60 | PINK1 | 0.93842087 |
| 61 | FER | 0.92696603 |
| 62 | CDK5 | 0.92292439 |
| 63 | STK38L | 0.91184186 |
| 64 | BRD4 | 0.90993428 |
| 65 | MAP2K4 | 0.89150142 |
| 66 | CAMK1 | 0.88455071 |
| 67 | PRKD1 | 0.86491969 |
| 68 | SIK2 | 0.86392519 |
| 69 | KSR2 | 0.86221367 |
| 70 | CDK12 | 0.84820471 |
| 71 | MAP3K2 | 0.79771191 |
| 72 | PDPK1 | 0.78451222 |
| 73 | CAMK2A | 0.74494774 |
| 74 | MAPK13 | 0.73406115 |
| 75 | CAMK1D | 0.72018679 |
| 76 | PDGFRB | 0.71554868 |
| 77 | FYN | 0.71257594 |
| 78 | MAP3K12 | 0.70184984 |
| 79 | KSR1 | 0.69970311 |
| 80 | BMPR2 | 0.69785730 |
| 81 | MAP3K7 | 0.69206301 |
| 82 | CAMK2G | 0.68937909 |
| 83 | CDK14 | 0.66664167 |
| 84 | PRKCE | 0.66591390 |
| 85 | RET | 0.65330519 |
| 86 | DDR2 | 0.64196955 |
| 87 | CAMK4 | 0.64170462 |
| 88 | MAP3K13 | 0.64052994 |
| 89 | MAPK12 | 0.63654979 |
| 90 | DMPK | 0.62788592 |
| 91 | ERBB3 | 0.62582567 |
| 92 | ERBB4 | 0.61520692 |
| 93 | MAP3K9 | 0.61423173 |
| 94 | ERBB2 | 0.60851525 |
| 95 | RPS6KA3 | 0.58707746 |
| 96 | PHKG2 | 0.58324094 |
| 97 | PHKG1 | 0.58324094 |
| 98 | FES | 0.58302993 |
| 99 | GSK3A | 0.57869984 |
| 100 | MAPK7 | 0.56102855 |
| 101 | NLK | 0.55949174 |
| 102 | TIE1 | 0.55527401 |
| 103 | CDK15 | 0.54395518 |
| 104 | NTRK2 | 0.51327336 |
| 105 | PIK3CA | 0.51233334 |
| 106 | PRKCG | 0.51228209 |
| 107 | RIPK4 | 0.50776654 |
| 108 | MAPK15 | 0.50497927 |
| 109 | PRKCH | 0.49796888 |
| 110 | CDK18 | 0.49786804 |
| 111 | YES1 | 0.48974550 |
| 112 | TRPM7 | 0.48621812 |
| 113 | ROCK1 | 0.48518436 |
| 114 | MAP3K4 | 0.48340234 |
| 115 | STK11 | 0.48198144 |
| 116 | PDK1 | 0.48074362 |
| 117 | GRK5 | 0.47672043 |
| 118 | DYRK2 | 0.47581305 |
| 119 | PRKCZ | 0.47181456 |
| 120 | PRKD3 | 0.46252505 |
| 121 | TESK2 | 0.45133288 |
| 122 | PTK2B | 0.44931986 |
| 123 | BMX | 0.44802591 |
| 124 | CDK11A | 0.44462503 |
| 125 | CSNK1D | 0.43054135 |
| 126 | NTRK3 | 0.41109695 |
| 127 | PRKG1 | 0.40983289 |
| 128 | PLK2 | 0.40463273 |
| 129 | INSR | 0.38835389 |
| 130 | SIK1 | 0.38273138 |
| 131 | CSNK1A1 | 0.37422910 |
| 132 | PRKACB | 0.36960915 |
| 133 | ARAF | 0.35823255 |
| 134 | SGK1 | 0.35619189 |
| 135 | EPHA3 | 0.34361645 |
| 136 | PTK2 | 0.33967295 |
| 137 | MINK1 | 0.33840734 |
| 138 | BMPR1B | 0.32668024 |
| 139 | CSK | 0.31525502 |
| 140 | MAPK10 | 0.31193752 |
| 141 | SRC | 0.31013256 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 4.82857442 |
| 2 | Steroid biosynthesis_Homo sapiens_hsa00100 | 4.44676152 |
| 3 | Fatty acid elongation_Homo sapiens_hsa00062 | 3.72189903 |
| 4 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 3.48792588 |
| 5 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.75094793 |
| 6 | Ether lipid metabolism_Homo sapiens_hsa00565 | 2.42896316 |
| 7 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.76748645 |
| 8 | Axon guidance_Homo sapiens_hsa04360 | 1.72920408 |
| 9 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.61087404 |
| 10 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.60789199 |
| 11 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.58833385 |
| 12 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.58369282 |
| 13 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.52912386 |
| 14 | Insulin secretion_Homo sapiens_hsa04911 | 1.51383393 |
| 15 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 1.49719078 |
| 16 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 1.43289268 |
| 17 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 1.40042965 |
| 18 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.34590763 |
| 19 | Histidine metabolism_Homo sapiens_hsa00340 | 1.31167581 |
| 20 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 1.26927636 |
| 21 | Glutamatergic synapse_Homo sapiens_hsa04724 | 1.22891024 |
| 22 | Circadian rhythm_Homo sapiens_hsa04710 | 1.21720955 |
| 23 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 1.19451042 |
| 24 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 1.18005606 |
| 25 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.17843761 |
| 26 | GABAergic synapse_Homo sapiens_hsa04727 | 1.16879269 |
| 27 | Renal cell carcinoma_Homo sapiens_hsa05211 | 1.15495957 |
| 28 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.09604236 |
| 29 | Taste transduction_Homo sapiens_hsa04742 | 1.08039620 |
| 30 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 1.07701343 |
| 31 | Long-term depression_Homo sapiens_hsa04730 | 1.02906629 |
| 32 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.02171360 |
| 33 | Glioma_Homo sapiens_hsa05214 | 1.01975846 |
| 34 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 1.00423616 |
| 35 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.99831109 |
| 36 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.99188999 |
| 37 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.99148215 |
| 38 | Tight junction_Homo sapiens_hsa04530 | 0.98545411 |
| 39 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.97113080 |
| 40 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.94231830 |
| 41 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.94160752 |
| 42 | Adherens junction_Homo sapiens_hsa04520 | 0.93123379 |
| 43 | Morphine addiction_Homo sapiens_hsa05032 | 0.92122635 |
| 44 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.91288231 |
| 45 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.91129766 |
| 46 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.87719351 |
| 47 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.87682093 |
| 48 | Melanogenesis_Homo sapiens_hsa04916 | 0.87413907 |
| 49 | Salivary secretion_Homo sapiens_hsa04970 | 0.86905362 |
| 50 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.85373287 |
| 51 | Endometrial cancer_Homo sapiens_hsa05213 | 0.84321135 |
| 52 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.84242376 |
| 53 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.82268160 |
| 54 | Circadian entrainment_Homo sapiens_hsa04713 | 0.81621002 |
| 55 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.81603009 |
| 56 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.81387735 |
| 57 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.81052225 |
| 58 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.80962203 |
| 59 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.80790102 |
| 60 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.77589009 |
| 61 | Endocytosis_Homo sapiens_hsa04144 | 0.77294581 |
| 62 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.73277463 |
| 63 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.73222951 |
| 64 | Platelet activation_Homo sapiens_hsa04611 | 0.72290871 |
| 65 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.71583064 |
| 66 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.71101596 |
| 67 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.70767988 |
| 68 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.70372368 |
| 69 | Renin secretion_Homo sapiens_hsa04924 | 0.70305612 |
| 70 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.69908075 |
| 71 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.68464442 |
| 72 | Dopaminergic synapse_Homo sapiens_hsa04728 | 0.68404002 |
| 73 | Olfactory transduction_Homo sapiens_hsa04740 | 0.68200176 |
| 74 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.67974623 |
| 75 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.66926858 |
| 76 | Mineral absorption_Homo sapiens_hsa04978 | 0.65774163 |
| 77 | Peroxisome_Homo sapiens_hsa04146 | 0.65670390 |
| 78 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.65555772 |
| 79 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.65314328 |
| 80 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.65014945 |
| 81 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.64444893 |
| 82 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.63507565 |
| 83 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 0.62909051 |
| 84 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.62565643 |
| 85 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.62252602 |
| 86 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.61385725 |
| 87 | Cocaine addiction_Homo sapiens_hsa05030 | 0.61100569 |
| 88 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.60731718 |
| 89 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.60484965 |
| 90 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.60454252 |
| 91 | Lysosome_Homo sapiens_hsa04142 | 0.60003116 |
| 92 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.58596377 |
| 93 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.57425155 |
| 94 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.57338483 |
| 95 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.57205689 |
| 96 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.56052711 |
| 97 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.55181201 |
| 98 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.54970851 |
| 99 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.54846834 |
| 100 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.54655956 |
| 101 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.53429773 |
| 102 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.53037300 |
| 103 | Long-term potentiation_Homo sapiens_hsa04720 | 0.52572631 |
| 104 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.52363886 |
| 105 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.51815721 |
| 106 | Nicotine addiction_Homo sapiens_hsa05033 | 0.51601273 |
| 107 | Bile secretion_Homo sapiens_hsa04976 | 0.50698319 |
| 108 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.50648434 |
| 109 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.50128955 |
| 110 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.49324908 |
| 111 | Gap junction_Homo sapiens_hsa04540 | 0.49260105 |
| 112 | Phototransduction_Homo sapiens_hsa04744 | 0.48908456 |
| 113 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.48018170 |
| 114 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.47781313 |
| 115 | Colorectal cancer_Homo sapiens_hsa05210 | 0.47656791 |
| 116 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.46430660 |
| 117 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.46380156 |
| 118 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.46060885 |
| 119 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.45026019 |
| 120 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.44863740 |
| 121 | Focal adhesion_Homo sapiens_hsa04510 | 0.44830882 |
| 122 | Phagosome_Homo sapiens_hsa04145 | 0.44441777 |
| 123 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.42097416 |
| 124 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.41813981 |
| 125 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.40836296 |
| 126 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.40742095 |
| 127 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.39336637 |
| 128 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.38928749 |
| 129 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.38816299 |
| 130 | Alzheimers disease_Homo sapiens_hsa05010 | 0.38716149 |
| 131 | Prion diseases_Homo sapiens_hsa05020 | 0.37739829 |
| 132 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.36837793 |
| 133 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.36632367 |
| 134 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.36473447 |
| 135 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.35616029 |
| 136 | ABC transporters_Homo sapiens_hsa02010 | 0.35455673 |
| 137 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.33786555 |
| 138 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.33786029 |
| 139 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.33771630 |
| 140 | Amoebiasis_Homo sapiens_hsa05146 | 0.33476843 |
| 141 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.32871152 |
| 142 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.31372054 |

